Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/24738
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Adenocarcinoma/drug therapy/mortality/secondary,Aged,Aged, 80 and over,Antineoplastic Combined Chemotherapy Protocols/*therapeutic use,Bone Neoplasms/drug therapy/mortality/secondary,Brain Neoplasms/drug therapy/mortality/secondary,Carcinoma, Large Cell/diagnosis/genetics,Carcinoma, Non-Small-Cell Lung/*drug therapy/*mortality/secondary,Carcinoma, Squamous Cell/drug therapy/mortality/secondary,Disease Progression,Female,Follow-Up Studies,Humans,Liver Neoplasms/drug therapy/mortality/secondary,Lung Neoplasms/drug therapy/mortality/pathology,Lymphatic Metastasis,Male,Middle Aged,Neoplasm Recurrence, Local/*drug therapy/mortality/pathology,Neoplasm Staging,Paclitaxel/administration & dosage,Small Cell Lung Carcinoma/drug therapy/mortality/secondary,Survival Rate,Treatment Outcome,Vinblastine/administration & dosage/analogs & derivatives
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/24738
ISSN: 1791-7530
Link: http://www.ncbi.nlm.nih.gov/pubmed/22213304
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά)

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons